GlaxoSmithKline, Novartis agree to CFIUs notification provision on three-part deal
MLex Summary: Swiss pharmaceutical company Novartis and UK-based GlaxoSmithKline agreed to inform each other within 30 days of their April 22 agreement on a three-part transaction of any intention to file...To view the full article, register now.
Already a subscriber? Click here to view full article